“…Mycoplasma hyopneumoniae is intrinsically resistant to antibiotics which interfere with the polymerization of cell wall precursors, such as beta‐lactam antibiotics and to polymyxins, 14‐membered ring macrolides (such as oleandomycin and erythromycin), trimethoprim and sulfonamides. In vitro , acquired resistance has been documented for tetracyclines, 15‐membered ring macrolides (tulathromycin, gamithromycin), 16‐membered ring macrolides (tylosin, tilmicosin), lincosamides (lincomycin) and fluoroquinolones (Felde, Kreizinger, Sulyok, Hrivnak, et al, ; Felde, Kreizinger, Sulyok, Marton, et al, ; Klein et al, ; Tavio, Poveda, Assunção, Ramírez, & Poveda, ; Vicca et al, ; Vicca et al, ). It was shown that mutations in the 23S rRNA gene were responsible for resistance to macrolides and lincosamides (Stakenborg et al, ).…”